Self reported STD incidence by HIV serostatus
| HIV serostatus | No | No of STD episodes reported in follow up | Incidence/100 PY (95% CI) | Incidence rate ratio (IRR) (95% CI) | p Value |
|---|---|---|---|---|---|
| All STDs: | |||||
| HIV positive at enrolment | 666 | 158 | 14.5 (12.3–16.9) | 2.8 (2.3–3.5) | <0.001 |
| Seroconverters | 147 | 67 | 16.8 (13.0–21.4) | 3.3 (2.5–4.3) | <0.001 |
| Non-seroconverters | 2476 | 257 | 5.1 (4.5–5.7) | Referent | — |
| Total | 3289 | 482 | 7.4 (6.7–8.1) | ||
| Genital ulcers: | |||||
| HIV positive at enrolment | 666 | 75 | 6.9 (5.4–8.6) | 4.1 (3.0–5.7) | <0.001 |
| Seroconverters | 147 | 34 | 8.5 (5.9–11.9) | 5.1 (3.3–7.7) | <0.001 |
| Non-seroconverters | 2476 | 84 | 1.7 (1.3–2.1) | Referent | — |
| Total | 3289 | 193 | 2.9 (2.5–3.4) | ||
| Urethral discharge: | |||||
| HIV positive at enrolment | 666 | 39 | 3.6 (2.5–4.9) | 2.2 (1.5–3.4) | <0.001 |
| Seroconverters | 147 | 18 | 4.5 (2.7–7.1) | 2.8 (1.6–4.8) | <0.001 |
| Non-seroconverters | 2476 | 80 | 1.6 (1.2–2.0) | Referent | — |
| Total | 3289 | 137 | 2.1 (1.8–2.5) |